Keyword Analysis & Research: mimedx

Keyword Analysis


Keyword CPC PCC Volume Score Length of keyword
mimedx0.4712555456

Keyword Research: People who searched mimedx also searched

Keyword CPC PCC Volume Score
mimedx1.110.8199731
mimedx group0.850.7337866
mimedx stock0.750.9653678
mimedx careers0.540.919313
mimedx marietta ga0.130.7686053
mimedx epifix1.680.1980699
mimedx stock price0.410.2321929
mimedx investor relations1.470.6334831
mimedx naics code0.551383190
mimedx connect1.760.1821457
mimedx stock yahoo0.710.3337696
mimedx axiofill1.260.6378928
mimedx logo1.770.2469654
mimedx group marietta ga0.210.2168360
mimedx kennesaw ga careers1.130.2363950

Search Results related to mimedx on Search Engine

  • Home | MIMEDX

    mimedx.com

    https://www.mimedx.com/

    WEBPAYER COVEREDLIVES. *BioMedGPS – SmartTRAK. 2022 US Amniotic Tissue Market – Revenues/Shares. https://www.smarttrak.com. Accessed April 13, 2023. MIMEDX is a pioneer and leader in placental biologics focused on delivering innovative solutions to patients and healthcare professionals.

    DA: 36 PA: 20 MOZ Rank: 19

  • Mimedx Group Inc (MDXG) Stock Price Today, Quote, Latest …

    stocktwits.com

    https://stocktwits.com/symbol/MDXG

    WEBTrack Mimedx Group Inc (MDXG) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.

    DA: 55 PA: 67 MOZ Rank: 33

  • Products Overview | MIMEDX

    mimedx.com

    https://www.mimedx.com/products-overview/

    WEBMIMEDX offers unique value to clinicians across sites of care. With a broad support system, we offer services to support needs relating to reimbursement and coverage, product access and cost containment, education, patient information, and clinical applications.

    DA: 52 PA: 95 MOZ Rank: 56

  • Company Overview | MIMEDX

    mimedx.com

    https://www.mimedx.com/company-overview/

    WEBWe do that by offering breakthrough innovations in advanced wound care and surgical applications. MIMEDX is a pioneer and leader in placental biologics focused on delivering innovative solutions to patients and the healthcare professionals who treat them.

    DA: 80 PA: 38 MOZ Rank: 7

  • EPIFIX | MIMEDX

    mimedx.com

    https://www.mimedx.com/epifix/

    WEBEPIFIX ® is a placental tissue allograft composed of dehydrated human amnion/chorion membrane (DHACM). It is available in sheet and mesh/fenestrated configurations in a variety of sizes to reduce wastage.

    DA: 94 PA: 53 MOZ Rank: 94

  • AMNIOFIX | MIMEDX

    mimedx.com

    https://www.mimedx.com/amniofix/

    WEBAMNIOFIX ® is a tissue allograft composed of dehydrated human amnion/chorion membrane (DHACM). It is available in sheet, fenestrated, and wrap configurations in a variety of sizes to reduce wastage.

    DA: 42 PA: 57 MOZ Rank: 28

  • MiMedx - Wikipedia

    wikipedia.org

    https://en.wikipedia.org/wiki/MiMedx

    WEBMiMedx Group is a biomedical company based in Marietta, Georgia, founded in 2008. It is traded on the NASDAQ as MDXG. The CEO is Tim Wright. Using tissues from birth such as the placenta, amniotic sac, and umbilical cord, MiMedx creates skin for skin grafts.

    DA: 78 PA: 76 MOZ Rank: 52

  • MIMEDX Announces Fourth Quarter and Full Year 2023 …

    mimedx.com

    https://investors.mimedx.com/news-releases/news-release-details/mimedx-announces-fourth-quarter-and-full-year-2023-operating-and

    WEBMARIETTA, Ga., Feb. 28, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), today announced operating and financial results for the fourth quarter and full year 2023. Recent Operating and Financial Highlights: Fourth quarter and full year 2023 net sales of $87 million and $321 million, reflecting 17% ...

    DA: 91 PA: 60 MOZ Rank: 10

  • General Surgery | MIMEDX

    mimedx.com

    https://www.mimedx.com/general-surgery/

    WEBSolutions in General and Colorectal Surgery. Advanced Placental-Based Allografts When Patients Are in Need.

    DA: 52 PA: 33 MOZ Rank: 10

  • MIMEDX Group, Inc. | MIMEDX Announces Launch of AXIOFILL™

    gcs-web.com

    https://mimedx.gcs-web.com/news-releases/news-release-details/mimedx-announces-launch-axiofilltm

    WEBMARIETTA, Ga., Sept. 20, 2022 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), a transformational placental biologics company, today announced the launch of AXIOFILL™, an Extracellular Matrix (ECM) Particulate product derived from human placental tissue.

    DA: 39 PA: 13 MOZ Rank: 89